Moderna

The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries. The agency authorized…
Read More...

Moderna Inc.’s Covid-19 vaccine is effective in children and adolescents, with mostly mild to moderate side effects, the US Food and Drug Administration staff said. “Available data support the effectiveness of the Moderna Covid-19 vaccine…
Read More...

US biotech firm Moderna said in a statement Thursday it had submitted a request for an emergency use authorization in the United States for its Covid vaccine for children aged six months to under six years. Children under six are the only…
Read More...

There is a 20 per cent chance that new Covid variants may be more dangerous that the ones already known, Moderna CEO Stéphane Bancel said in an interview on Thursday amid a fresh surge in many countries in the world. “I think there’s an 80…
Read More...

Moderna Inc. on late Thursday sought emergency use authorization with US health regulators for a second COVID-19 booster shot for all adults, as a surge in cases in some parts of the world fuels fears of another wave of the pandemic. The…
Read More...

A group of 3,000 volunteers in the UK will be among the first in the world to receive a new COVID-19 vaccine that targets the omicron variant, Sky News reported. Almost 30 hospitals across the UK are expected to take part in the tests,…
Read More...

The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday. Though it’s now well…
Read More...

US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the omicron variant of the coronavirus. The trials will involve a total of 600 adults — half…
Read More...

Amid the scare of the new COVID-19 variant Omicron and the demand for booster shots of the vaccine, American biotechnology company Moderna, on Monday, said that its COVID-19 booster shot appears to increase antibody levels against the…
Read More...

Moderna Inc said on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against the fast-spreading Omicron variant in laboratory testing and that the current version of the vaccine would continue to be Moderna’s…
Read More...